B
BioCryst Pharmaceuticals, Inc. (BCRX)
9.33
0.00 (0.00%)
Get all premium features to the best stock analysis tool
9.33
0.00 (0.00%)
This stock has a consensus price target of $19.80 based on the ratings of 15 analysts. The high is $32.00 and the low is $9.00.
| Target | Lowest Price Target | Consensus Price Target | Highest Price Target |
|---|---|---|---|
| Price | $ 9 | $ 19.8 | $ 32 |
| Change | -3.54% | 112.22% | 242.98% |
| Date | Upside/Downside | Analyst Firm | Price Target | Rating Change | Rating |
|---|---|---|---|---|---|
| 2026-01-30 | 39.34% | RBC Capital | $14 → $13 | Maintains | Outperform |
| 2025-12-15 | 242.98% | HC Wainwright & Co. | $30 → $32 | Maintains | Buy |
| 2025-11-05 | 167.95% | Citizens | $27 → $25 | Maintains | Market Outperform |
| 2025-11-04 | -3.54% | Barclays | $11 → $9 | Maintains | Equal-Weight |
| 2025-11-04 | 92.93% | Needham | $20 → $18 | Maintains | Buy |